Literature DB >> 6272666

Studies on the neutralizing antibody to herpes simplex virus. II. Quantitative analysis of type specific antibodies in rabbits immunized with both types of virus.

M Ohashi, Y Ozaki.   

Abstract

A quantitative analysis was carried out on type specific antibody developed in rabbits primed with three doses of one type of herpes simplex virus at two week intervals, followed by administration of another type of virus. Complement-requiring neutralizing antibody assay and mutual absorbing methods were used. The homotype specific antibody produced against the type of virus used for priming persisted at a constant level for a long period, despite the lack of antigenic stimuli by the same type after priming. The homotype specific antibody was not affected by the heterotypic antigenic stimuli. On the other hand, the heterotype specific antibody developed after the first or second injection of heterotypic virus, and the titer tended to decline, reaching undetectable levels at 9 months. However, the heterotype specific antibody was produced rapidly after the third injection of virus at 9 months and the titers exceeded or closed to those of the homotype specific antibody. The homotype specific antibodies were mainly distributed in the IgG fraction, while the IgM fraction contained mainly the heterotype specific antibodies. In relationship between type specific antibody response and the values of II/I index, the coexistence of both type specific antibodies was apparent in sera with the values of 91 to 117 of II/I index and in the IgG fraction with the values of 90 to 115, respectively.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272666     DOI: 10.1007/bf01315154

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  THE APPEARANCE OF COMPLEMENT-REQUIRING NEUTRALIZING ANTIBODIES BY IMMUNIZATION AND INFECTION WITH HERPES SIMPLEX VIRUS.

Authors:  K YOSHINO; S TANIGUCHI
Journal:  Virology       Date:  1964-02       Impact factor: 3.616

Review 2.  The causative role of herpesvirus type 2 in cervical cancer.

Authors:  J L Melnick; E Adam; W E Rawls
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

3.  Genital herpes in two social groups.

Authors:  W E Rawls; H L Gardner; R W Flanders; S P Lowry; R H Kaufman; J L Melnick
Journal:  Am J Obstet Gynecol       Date:  1971-07-01       Impact factor: 8.661

4.  Antibodies to Herpesvirus hominis types 1 and 2 in the rabbit.

Authors:  A J Nahmias; W R Dowdle; J H Kramer; C F Luce; S C Mansour
Journal:  J Immunol       Date:  1969-04       Impact factor: 5.422

5.  A serologic study of herpesvirus hominis strains by microneutralization tests.

Authors:  F P Pauls; W R Dowdle
Journal:  J Immunol       Date:  1967-05       Impact factor: 5.422

6.  Comparative studies of type 1 and type 2 & 'herpes simplex' viruses.

Authors:  G Plummer; J L Waner; C P Bowling
Journal:  Br J Exp Pathol       Date:  1968-04

7.  The association of herpesvirus type 2 and carcinoma of the uterine cervix.

Authors:  W E Rawls; W A Tompkins; J L Melnick
Journal:  Am J Epidemiol       Date:  1969-05       Impact factor: 4.897

8.  Relationship between antigenic type of virus and antibody response in female patients with herpes genitalis.

Authors:  Y Ozaki; T Ishiguro; M Ohashi; E M Kimura
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

9.  Effect of cross-immunization on monotypic antibody responses to herpes simplex virus types 1 and 2.

Authors:  J W Smith; J C Glorioso
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

10.  Antibodies to Herpesvirus hominis types 1 and 2 in humans. II. Women with cervical cancer.

Authors:  A J Nahmias; W E Josey; Z M Naib; C F Luce; B A Guest
Journal:  Am J Epidemiol       Date:  1970-06       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.